Invivyd to host call to announce interim Phase 3 DECLARATION trial results on November 23, 2026
FROM THE WIRE · GLOBENEWSWIRE.COM
NEW HAVEN, Conn., Nov. 22, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that it will host an investor call to announce results from an interim analysis of the ongoing Phase 3 DECLARATION clinical trial on Monday, November 23, 2026 at 8:30 a.m.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralPhase 3 trial results can move a small biotech's shares, but the direction is not yet known from this announcement.AI-generated summary
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets